Theratechnologies Inc.
TH.TO
TSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 25.00M | 22.60M | 22.02M | 16.25M | 23.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.00M | 22.60M | 22.02M | 16.25M | 23.45M |
| Cost of Revenue | 6.10M | 4.52M | 4.55M | 5.28M | 5.07M |
| Gross Profit | 18.91M | 18.08M | 17.47M | 10.96M | 18.39M |
| SG&A Expenses | 10.66M | 9.25M | 9.46M | 9.46M | 7.40M |
| Depreciation & Amortization | 1.44M | -- | -- | -- | 2.51M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.08M | 16.39M | 18.73M | 18.49M | 18.82M |
| Operating Income | 919.00K | 6.21M | 3.29M | -2.25M | 4.63M |
| Income Before Tax | -6.88M | 3.85M | 1.11M | -4.37M | -2.68M |
| Income Tax Expenses | 1.02M | 756.00K | 118.00K | 110.00K | 73.00K |
| Earnings from Continuing Operations | -7.90M | 3.09M | 987.00K | -4.48M | -2.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.90M | 3.09M | 987.00K | -4.48M | -2.76M |
| EBIT | 919.00K | 6.21M | 3.29M | -2.25M | 4.63M |
| EBITDA | 1.33M | 6.62M | 4.47M | -1.81M | 5.13M |
| EPS Basic | -0.16 | 0.06 | 0.02 | -0.09 | -0.08 |
| Normalized Basic EPS | -0.01 | 0.05 | 0.01 | -0.06 | 0.00 |
| EPS Diluted | -0.16 | 0.06 | 0.02 | -0.09 | -0.08 |
| Normalized Diluted EPS | -0.01 | 0.05 | 0.01 | -0.06 | 0.00 |
| Average Basic Shares Outstanding | 49.36M | 49.36M | 49.36M | 49.36M | 32.72M |
| Average Diluted Shares Outstanding | 49.36M | 49.37M | 49.37M | 49.36M | 32.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
